<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01716273</url>
  </required_header>
  <id_info>
    <org_study_id>RRK4106</org_study_id>
    <nct_id>NCT01716273</nct_id>
  </id_info>
  <brief_title>Use of White Granulated Sugar on Wounds</brief_title>
  <official_title>A Randomised Controlled Trial to Investigate the Clinical and Cost-effectiveness of White Granulated Sugar Dressing Compared With Standard Treatment in the Management of Exudating Wounds With Parallel Economic Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moses Murandu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Laboratoires URGO</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Wolverhampton</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Birmingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Birmingham</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      How effective is sugar in reducing the debriding of sloughy, necrotic or infected exudating
      wounds compared with standard treatment?
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients for whom all the following apply:

      Have an exudating wound sizes 5cm2 and 40cm2 A minimum of 25% slough, infected and necrotic
      tissue No dry necrotic eschar present Ankle Brachial Pressure Index of greater than 0.6 Are
      over 18 years Independently and willingly consent
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2011</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to debridement of wound</measure>
    <time_frame>4 weeks</time_frame>
    <description>wounds will be photographed at entry into the study there after weekly till end of study at 4 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in wound surface area</measure>
    <time_frame>4 weeks</time_frame>
    <description>Wound measurements will be taken at entry into the study then weekly until end of 4 weeks</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life</measure>
    <time_frame>4 weeks</time_frame>
    <description>Participants will be given a QOL questionnaire to complete before commencing the treatment and at the end of the 4 weeks</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Infected Wounds</condition>
  <arm_group>
    <arm_group_label>Chronic &amp; Acute infected wounds</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Wound will be cleaned with normal saline or tap water and Granulated sugar will be applied directly to the wound and covered with an absorbent pad and held in place with a bandage and tape.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic and Acute infected wounds</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wound will be cleaned with normal saline or tap water and an appropriate debridement dressing (Aquacel or Sorbsan) is applied to the wound and secured with a bandage and surgical tape.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Granulated Sugar</intervention_name>
    <description>30 grams of granulated sugar is used to cover the wound area and this is held in place using a dry dressing pad , bandage and tape.</description>
    <arm_group_label>Chronic &amp; Acute infected wounds</arm_group_label>
    <arm_group_label>Chronic and Acute infected wounds</arm_group_label>
    <other_name>Sucrose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Debridement Dressing</intervention_name>
    <description>1 Aquacel or Sorbsan dressing will be put over the wound, and held in place with a dry dressing pad, bandage and tape.</description>
    <arm_group_label>Chronic &amp; Acute infected wounds</arm_group_label>
    <arm_group_label>Chronic and Acute infected wounds</arm_group_label>
    <other_name>Aquacel or Sorbsan</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Exudating wound sizes 5cm2 and 40cm2

          -  A minimum of 25% slough, infected and necrotic tissue

          -  No dry necrotic eschar

          -  Ankle Brachial Pressure Index of greater than 0.6

          -  Age over 18 years

          -  Able to independently and willingly consent

        Exclusion Criteria:

          -  Participants in a trial evaluating other therapies for their wound

          -  Have previously been in this trial

          -  Women who are pregnant

          -  Participants not able to tolerate daily dressing change
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Malcolm Simms, MBBSFRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Birmingham NHS Fondation Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moses Murandu, PhD student</last_name>
    <role>Study Director</role>
    <affiliation>University of Wolverhampton</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Moses Murandu, PhD student</last_name>
    <phone>07743025072</phone>
    <email>mosesmurandu@wlv.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Malcolm Simms, MBBSFRCS</last_name>
    <phone>07768147025</phone>
    <email>malcolm.simms@uhb.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Birmingham NHS Foundation Trust</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Hornabrook</last_name>
      <phone>0121 697 8311</phone>
      <email>rachel.hornabrook@uhb.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Carol Dealey, PhD</last_name>
      <phone>0121 697 8311</phone>
      <email>carol.dealey@uhb.nhs.uk</email>
    </contact_backup>
    <investigator>
      <last_name>Moses Murandu, PhD student</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Murandu M, Webber MA, Simms MH, Dealey C. Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study. J Wound Care. 2011 May;20(5):206, 208, 210 passim.</citation>
    <PMID>21647066</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2012</study_first_submitted>
  <study_first_submitted_qc>October 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2012</study_first_posted>
  <last_update_submitted>October 26, 2012</last_update_submitted>
  <last_update_submitted_qc>October 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Birmingham</investigator_affiliation>
    <investigator_full_name>Moses Murandu</investigator_full_name>
    <investigator_title>PhD student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Wound Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carboxymethylcellulose Sodium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

